These findings suggest that CHAF1A may participate in the regulation of neonatal birth weight in GDM, provide new insights into the pathogenesis of GDM-related macrosomia and offer potential targets for future intervention strategies. This evidence concerns the gene CHAF1A and gestational diabetes.